TARS - Tarsus Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$84.00
DETAILS
HIGH:
$100.00
LOW:
$68.00
MEDIAN:
$84.00
CONSENSUS:
$84.00
UPSIDE:
34.92%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 93.2% |
| EBIT Margin | -12.3% |
| EBITDA Margin | -11.9% |
| Operating Margin | -15.7% |
| Pretax Margin | -14.3% |
| Cont. Ops Margin | -14.7% |
| Net Margin | -14.7% |
| Bottom Line Margin | -14.7% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 3.85 |
| Quick Ratio | 3.82 |
| Solvency Ratio | -0.295 |
| Cash Ratio | 1.35 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-51.51
Peers avg: 19.6
|
| PEG Ratio | 1.07 |
| Forward PEG | 1.07 |
| Price/Book | 9.96 |
| Price/Sales | 7.58 |
| Price/FCF | -153.35 |
| Price/Op Cash Flow | -274.78 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1666 |
| Debt/Equity | 0.2727 |
| Debt/Capital | 0.2142 |
| Long-Term Debt/Capital | 0.1947 |
| Financial Leverage | 1.64 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 1.36 |
| Operating Cash Flow Ratio | -0.092 |
| Operating Cash Flow/Sales | -2.8% |
| Free Cash Flow/Operating Cash Flow | 179.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -6.23 |
| Interest Coverage | -7.9428 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -0.13 |
| Capital Expenditure Coverage | -1.26 |
| Dividend + Capital Expenditure Coverage | -1.26 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 10.80 |
| EPS | -1.590 |
| Debt/Share | 2.4548 |
| Cash/Share | 9.99 |
| Book Value/Share | 8.22 |
| Tangible BV/Share | 8.04 |
| Equity/Share | 8.22 |
| Operating Cash Flow/Share | -0.298 |
| Capital Expenditure/Share | 0.236 |
| FCF/Share | -0.534 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.032 |
| Earnings Before Tax/EBIT | 0.907 |
| Price/Fair Value | 9.96 |
| Debt/Market Cap | 0.0243 |
| Effective Tax Rate | -3.2% |
| Enterprise Value Multiple | -62.14 |